|
HS Code |
424725 |
| Chemical Name | 3-(4-Methylbenzoyl)Propionic Acid |
| Synonyms | 4'-Methyl-3-propionylbenzoic acid |
| Molecular Formula | C11H12O3 |
| Molecular Weight | 192.21 g/mol |
| Cas Number | 4511-42-6 |
| Appearance | White to off-white solid |
| Melting Point | 96-100°C |
| Solubility | Slightly soluble in water; soluble in organic solvents |
| Storage Conditions | Store at room temperature, in a dry and well-ventilated place |
| Purity | Typically ≥98% |
| Smiles | CC1=CC=C(C=C1)C(=O)CCC(=O)O |
As an accredited 3-(4-Methylbenzoyl)Propionic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 100g 3-(4-Methylbenzoyl)Propionic Acid is supplied in a sealed amber glass bottle with a tamper-evident screw cap. |
| Shipping | 3-(4-Methylbenzoyl)propionic acid is shipped in tightly sealed containers to prevent moisture or contamination. It should be protected from direct sunlight and stored in a cool, dry place. Transportation follows standard chemical handling protocols, with appropriate labeling and documentation, ensuring compliance with applicable safety and regulatory guidelines. |
| Storage | Store **3-(4-Methylbenzoyl)propionic acid** in a tightly sealed container, protected from light, moisture, and incompatible materials such as strong bases and oxidizing agents. Keep it in a cool, dry, and well-ventilated area, ideally in a designated chemical storage cabinet. Always follow standard laboratory safety protocols and ensure appropriate labeling for safe identification and handling. |
Applications of 3-(4-Methylbenzoyl)Propionic Acid in Industrial Manufacturing3-(4-Methylbenzoyl)Propionic Acid plays a key role as a high-purity intermediate for multiple industrial sectors. As direct manufacturer, we ensure reliable quality for complex downstream processes, offering dedicated supply for advanced formulations and exacting production requirements. 1. Nonsteroidal Anti-inflammatory Drug (NSAID) SynthesisThis compound acts as a core building block in the synthesis of fenoprofen calcium and related propionic acid derivatives. Its defined aromatic and propionic acid structure supports selective acylation in pharmaceutical APIs. Leading formulators apply this intermediate to precisely controlled steps to attain desired isomer ratios, reaction purity, and meet strict impurity profiles demanded by regulated drug manufacturing environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Fine Chemical Intermediates for Fragrance SynthesisThis aromatic acid functions as an intermediate in custom fragrance molecule production, especially for musk and floral compounds. Manufacturers use its controlled reactivity under Friedel–Crafts acylation or esterification steps to introduce specified aromatic structures. Its predictable purity profile ensures minimal by-product generation under high throughput fragrance chemical operations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Coating Resins Raw MaterialThe propionic acid moiety enables formulation chemists to design resins with enhanced flexibility, UV stability, and surface properties by introducing this intermediate into custom polyester or acrylic resin synthesis. By selecting precise reaction conditions and stoichiometry, coating manufacturers achieve desirable molecular weights and adjust crosslinking density, directly influencing performance in industrial coatings. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. API Intermediate Supplier for Contract Manufacturing (CMO) OperationsAs part of multi-step synthesis routes for contract manufacturing organizations, this acid supports flexible volume scaling in pharmaceutical intermediate production. CMOs require consistent supply of high-purity material to minimize process deviations during batch or continuous operations, especially for regulatory filings and new generic drug launches. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3-(4-Methylbenzoyl)Propionic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
3-(4-Methylbenzoyl)Propionic Acid has become an integral intermediate across multiple industries, particularly in pharmaceutical synthesis and advanced materials research. Our production draws on years of experience with aromatic acids, carbonylic building blocks, and precise functionalization of hydrocarbon backbone compounds. Every batch emerges from a tightly controlled process that aims for consistency in purity, color, and crystalline form.
We focus on manufacturing 3-(4-Methylbenzoyl)Propionic Acid with a purity level consistently above 99%, measured using HPLC and NMR. The structural specificity of this compound, combining a propionic acid group with a para-methyl-substituted benzoyl moiety, delivers performance in synthetic routes not found in more generic aromatic acids. Customers often mention its predictability during scale-up and selective reactivity that streamlines key transformations. Unlike its close counterpart 3-benzoylpropionic acid, the methyl group at the para-position alters both its reactivity and physical properties, favoring certain types of alkylation and condensation reactions. Folklore among chemists often points to unreliable sources where slight contaminants from mishandled methylbenzoic feedstock compromise end-product effectiveness. We avoid these pitfalls thanks to rigorous analytical controls at every stage.
Chemists working with complex molecule synthesis depend on reproducibility and a clear analytical fingerprint. Our technical team runs full suites of GC-MS, melting point, moisture content, and ultraviolet spectrum checks. These steps help partners at pharmaceutical companies, contract labs, and R&D outfits minimize costly troubleshooting downstream. The unique molecular design of 3-(4-Methylbenzoyl)Propionic Acid improves yields in certain NSAID and cardiovascular compound syntheses, particularly where selective aryl ketone addition is needed. We have seen research projects gain momentum just from switching to this compound, as it outperforms less tailored benzoic or propionic acid derivatives.
Direct users know well the headaches of inconsistent substrates leading to poor reaction selectivity or hard-to-remove byproducts. 3-(4-Methylbenzoyl)Propionic Acid brings a dependable entry point into many heterocyclic frameworks, especially those requiring a stable, non-halogenated para-aromatic group. Over the years, we have supported projects for COX inhibitor precursors, certain amphetamine derivatives, and specialty fluorophores. The robust carbonyl group on the propionic side-chain acts as a handle for ring closures or as a starting point for further alkylation. These features give it clear advantages over classical benzoylpropionic acids, which often fall short where steric or electronic selectivity is critical.
Choosing the right supplier for 3-(4-Methylbenzoyl)Propionic Acid goes beyond finding a technical grade listing. The path from raw methylbenzoic acid and propionic acid to the final, purified product introduces opportunities for contamination or side-reactions. Over the decades, our facility has built up a kind of in-house “muscle memory” for these reactions, relying on experienced eyes, not only instruments, to check for signs of off-spec color or odor. Some of our veteran operators recall firsthand the introduction of new analytical techniques or the first time a scale-up batch unexpectedly formed an intractable solid. These little details matter, because they allow us to address root causes before they become customer complaints.
Most of our production runs yield a fine, nearly white crystalline powder with a melting point tightly clustered around the 95–99 °C mark, verified by repeated DSC measurements. Moisture content is monitored using Karl Fischer titration to ensure the product remains below 0.2% water before packaging. These physical traits come after several filtration and recrystallization steps, which we have optimized over years of trial and error to avoid solvent inclusion, agglomeration, or trace metallic contamination. For users with sensitive downstream chemistry, such attention to detail means less time spent on repurification.
Handling recommendations developed at our site favor glass or lined vessels, since high-purity samples can pick up unwanted flavors from some plastics during extended storage. Our warehouse managers prefer to store this acid in a low-humidity, neutral-pH environment, away from strong bases and oxidizers. Customers can request packaging in single-use fluoropolymer bags, which eliminate any static charge issues, especially for those scale-up labs practicing GMP or ISO-based workflows.
Academic groups and industrial users often share stories about headaches caused by inconsistent aroma, off-shades, or trace polymerization in aromatic substrate lots. In our view, small variations in manufacturing make outsized impacts by introducing “invisible variables” into a lab’s workflow—hours lost on purification, uncertainty in NMR integrations, or even compound instability over time. We designed our process to fix these pain points. Milestones like achieving a 99.9% single spot on TLC or eliminating measurable solvent residue have come from careful engineering, not just hope. Our QC team routinely cross-analyzes against both in-house and third-party standards. We have learned that tolerating excuses such as “that’s just the nature of this material” is not compatible with high-throughput, quality-focused chemistry.
3-(4-Methylbenzoyl)Propionic Acid stands apart from products like 4-methylbenzoic acid, benzoylpropionic acid, or benzoic acid derivatives lacking the methyl group. The para-methyl shift tunes both electron distribution and steric accessibility across the benzoyl group, affecting rates of nucleophilic attack, transesterification, and radical additions. Customers working in specific areas—developing pain relievers, designing light-absorbing dyes, building polymer components—comment on altered reactivity profiles when switching between these molecules. From a synthetic planning standpoint, the choice of precursor can make or break the development window for pharma launches or novel reagents. We gather feedback regularly to understand where our product streamlines these steps, and we investigate outliers where expected reactivity does not match bench results.
Running a chemical plant for specialty organics means managing cycles of raw material quality, reaction optimization, and purification logistics. A recent batch utilized an improved crystallization solvent system, cutting time-to-dry by almost 10% and raising batch-to-batch consistency in color and particle size. Over the last five years, we have upgraded containment and ventilation to minimize any risk of workplace exposure, which keeps both our operators and final product quality in check. Continuous inline monitoring for pH and Karl Fischer titration at every stage means each lot can be traced to a specific set of operating parameters. Long before a drum leaves our warehouse, each identifier tracks against not just analytical results but operator notes—highlighting run temperature, any visual anomalies, and analytical checkpoint approval.
As producers, we view sustainability not as a checklist but as a competitive lever. We work on solvent recycling, energy reduction during distillation, and reduction of hazardous byproducts. Over the last several years, our optimization of methylbenzoic acid conversion steps reduced both aqueous and organic waste levels, responding to both environmental and economic goals. Regulatory requirements have pushed for both traceability and minimization of residuals, and we routinely participate in external audits to prove that our practices match our claims. In conversations with university research partners, we exchange information about catalysts or new green chemistry approaches, keeping both production and product lifecycle moving toward lower overall environmental impact.
Pharmaceutical intermediates live in a perpetual balancing act between cost, availability, and strict impurity profiles. Our plant built out dedicated lines to supply 3-(4-Methylbenzoyl)Propionic Acid at larger scale when customers shifted from pilot to commercial batches for novel APIs. One major pharmaceutical company reported that their switch enabled them to skip one entire purification stage in their NSAID workflow, due to predictable reactivity and cleaner analytical background by LC-MS. Such small process wins cascade into faster regulatory filing, reduced outsourced analysis, and lighter quality documentation.
Research-driven teams have used our product to test newer condensation, reduction, and cyclization techniques. The compound’s aromatic structure tolerates a range of reaction conditions without significant degradation, and its carboxylic acid tail offers handy reactivity for activating chemistry. To serve these innovators, we shift our supply volumes rapidly, tracking demand signals from academia, contract research organizations, and integrated drug houses.
Our links to both scientists and purchasing teams create a feedback loop that extends far past the initial transaction. Field support helps interpret analytical ambiguities, and our technical bench can verify customer data on melting points, spectral purity, or impurity troubleshooting. Years of involvement with global launches for generic APIs exposed us to wildly different regulatory and processing realities. This background pushed us to adjust both documentation and physical presentation, including full batch traceability, full analytical raw data, and breakdowns of minor impurity structures where relevant.
Working side-by-side with production chemists also means learning about non-ideal storage, lab mishaps, and the ways chemicals must perform outside of well-controlled warehouse or production settings. We encourage sharing “incidents” in use, which has resulted in practical changes: improved desiccant packaging, new lot color coding, and reminders about exposure to sunlight that affects color stability.
The quality mindset at our company traces to a culture of active listening, repeated measurement, and active accountability. Instead of relying just on end-point testing, we developed ongoing in-process controls. Our pride stems from the days when a single spot TLC eluded us, and we labored through long purification nights to secure that batch. We continue to pool laboratory, engineering, and logistics resources toward making steps leaner and less labor-intensive—so we can devote more time to troubleshooting, process improvement, and customer engagement.
By tracking customer outcomes over many years, we moved beyond raw purity numbers to understanding “how” purity impacts yield, intermediate stability, or ease of separation. This thinking feeds back into our manufacturing adjustments, driven by real-world, on-the-bench research rather than just supplier-driven targets.
Every shipment gets better as partners and our own team report back on details: an unexplained haze in solution, an off-smell after six months in storage, or a lumpy solid instead of free-flowing powder. We collect this feedback systematically, revising blend protocols, shelf-life testing, and even crystal habit modification. Sometimes, improvements come from small tweaks—changing a drying step or introducing a secondary filter that reduces fine dust in packaging. Other times, larger investments are required, such as installing new analytical instruments or switching to certified solvent systems.
The commitment extends to running parallel batches for custom requests, supporting lower-salt variants, or preparing application-specific particle size ranges. We have invested in regular staff training, making sure our chemists, operators, and warehouse staff understand not only the “what” but the “why” behind each procedural step.
Changes in end-user demands, whether from new pharmaceutical filings, changed environmental regulations, or breakthroughs in chemical methodology, push us to periodically revisit and sharpen our own specifications. If a new impurity limit for regulatory filings is announced, or if academic researchers demonstrate previously unrecognized degradation under a certain set of conditions, we integrate those learnings into our own process within weeks, not years.
Being a manufacturer means learning not to chase every hypothetical application, but to invest in depth on what matters most—batch-to-batch reproducibility, clear documentation, and a human-level awareness of how chemistry and logistics intersect. Over the years, many users mention a degree of confidence switching from generic suppliers to a veteran producer—knowing the supply chain, storage, and handling practices form a complete and reliable package.
Manufacturing 3-(4-Methylbenzoyl)Propionic Acid has taught us that fine details—solvent residues, trace impurities, crystal habit—carry real-world consequences in advanced organic synthesis. Our role as a producer includes sharing best practices, supporting partners across regulatory and research divides, and investing in process innovations that yield cleaner, purer, and more effective outputs. As we move forward, the feedback loop between operator experience, analytical data, and end-customer results will keep driving improvements, so customers can rely on consistency batch after batch.
What distinguishes us is not only our chemical formula, but accumulated expertise, commitment to forward-thinking quality, and a partnership mentality that draws on facts and shared experience to keep both the science and supply moving in the right direction. The lessons learned from every batch echo back into every future shipment.